In yesterday’s Wall Street session, Alpine Immune Sciences Inc (NASDAQ:ALPN) shares traded at $64.40, up 36.90% from the previous session.
ALPN stock price is now 86.21% away from the 50-day moving average and 237.60% away from the 200-day moving average. The market capitalization of the company currently stands at $4.22B.
With the price target of $55, Guggenheim recently initiated with Buy rating for Alpine Immune Sciences Inc (NASDAQ: ALPN). On February 15, 2024, Wolfe Research recently initiated its ‘Outperform’ rating on the stock quoting a target price of $44, while ‘Berenberg’ rates the stock as ‘Buy’
In other news, Rickey James Paul, insider sold 117,764 shares of the company’s stock on Jan 26 ’24. The stock was sold for $2,745,830 at an average price of $23.32. Upon completion of the transaction, the insider now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 25 ’24, Rickey James Paul sold 236 shares of the business’s stock. A total of $5,192 was realized by selling the stock at an average price of $22.00. A total of 28.22% of the company’s stock is owned by insiders.
During the past 12 months, Alpine Immune Sciences Inc has had a low of $6.71 and a high of $47.84. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 7.86, and a quick ratio of 7.86. The fifty day moving average price for ALPN is $35.36 and a two-hundred day moving average price translates $19.34 for the stock.
The latest earnings results from Alpine Immune Sciences Inc (NASDAQ: ALPN) was released for Dec, 2023. According to the Biotechnology Company, earnings per share came in at $0.12, beating analysts’ expectations of -$0.34 by 0.46. This compares to -$0.46 EPS in the same period last year. The net profit margin was -54.66% and return on equity was -12.69% for ALPN. The company reported revenue of $30.85 million for the quarter, compared to $2.78 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 1011.42 percent. For the current quarter, analysts expect ALPN to generate $3.52M in revenue.
